Literature DB >> 3011235

The experience and effectiveness of the Nova Scotia Rh program, 1964-84.

T F Baskett, M L Parsons, L J Peddle.   

Abstract

A program to reduce the incidence of erythroblastosis fetalis was started in Nova Scotia in 1964. Up to the end of 1984, 120 fetuses received 247 intrauterine transfusions. The survival rate was 45.6% in the first 10 years of the program and 66.7% in the next 11 years. For fetuses at or over 26 weeks' gestation the figures were 51.5% and 73.7% respectively. Postpartum prevention was started in 1968, with administration of Rh immune globulin (RhIG) to Rh-negative unimmunized women within 72 hours after the birth of an Rh-positive infant. Antepartum prevention, started in 1979, consisted of administration of RhIG at 28 weeks' gestation to Rh-negative unimmunized women. The effectiveness of the prevention program was evaluated by enumerating the known cases of Rh(D) alloimmunization in the province from 1982 to 1984: 55 cases were identified, a rate of 1.5 per 1000 births instead of the expected rate of about 10 per 1000.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011235      PMCID: PMC1491101     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  12 in total

1.  Ultrasound as an aid in intrauterine transfusion.

Authors:  P L Cooperberg; C W Carpenter
Journal:  Am J Obstet Gynecol       Date:  1977-06-01       Impact factor: 8.661

Review 2.  The management of Rh-Isoimmunization.

Authors:  J M Bowman
Journal:  Obstet Gynecol       Date:  1978-07       Impact factor: 7.661

3.  Rh(D) haemolytic disease of the newborn: the changing scene.

Authors:  S J Urbaniak
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-06

4.  Five years' experience with intrauterine transfusion.

Authors:  J M Corston; E Pereira; D W Cudmore; B S Morton
Journal:  Can Med Assoc J       Date:  1970-09-26       Impact factor: 8.262

5.  Rh isoimmunization, Manitoba, 1963-75.

Authors:  J M Bowman; B Chown; M Lewis; J Pollock
Journal:  Can Med Assoc J       Date:  1977-02-05       Impact factor: 8.262

6.  Intrauterine fetal transfusion in 365 fetuses during fifteen years.

Authors:  F D Frigoletto; I Umansky; J Birnholz; D Acker; C L Easterday; G B Harris; N T Griscom
Journal:  Am J Obstet Gynecol       Date:  1981-04-01       Impact factor: 8.661

7.  The management of severe rhesus isoimmunization by fetoscopic intravascular transfusions.

Authors:  C H Rodeck; K H Nicolaides; S L Warsof; W J Fysh; H R Gamsu; J R Kemp
Journal:  Am J Obstet Gynecol       Date:  1984-11-15       Impact factor: 8.661

8.  Intrauterine fetal transfusions: Winnipeg 1982.

Authors:  J M Bowman; F A Manning
Journal:  Obstet Gynecol       Date:  1983-02       Impact factor: 7.661

9.  Severe Rh disease--poor outcome is not inevitable.

Authors:  C R Harman; F A Manning; J M Bowman; I R Lange
Journal:  Am J Obstet Gynecol       Date:  1983-04-01       Impact factor: 8.661

10.  Rh immunization in Manitoba: progress in prevention and management.

Authors:  J M Bowman; J Pollock
Journal:  Can Med Assoc J       Date:  1983-08-15       Impact factor: 8.262

View more
  2 in total

1.  Prevention of Rh(D) alloimmunization: a cost-benefit analysis.

Authors:  T F Baskett; M L Parsons
Journal:  CMAJ       Date:  1990-02-15       Impact factor: 8.262

2.  Constructing a population-based research database from routine maternal screening records: a resource for studying alloimmunization in pregnant women.

Authors:  Brian K Lee; Alexander Ploner; Zhongxing Zhang; Gunilla Gryfelt; Agneta Wikman; Marie Reilly
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.